1,139 results match your criteria: "Hubei Cancer Hospital[Affiliation]"

Skimmed milk intake reduces the risk of ER- breast cancer: a Mendelian randomization analysis.

Discov Oncol

November 2024

Department of Lymphoma Medicine, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430079, China.

Background: In prior observational investigations, it has been demonstrated that the consumption of milk is associated with the incidence of breast cancer (BC). Despite the existence of a two-sample Mendelian randomization (MR) that suggests a causal relationship between milk intake and breast cancer risk, the outcomes still lack a definitive conclusion. This ambiguity may be attributed to variables such as the variety of milk ingested, estrogen levels, the specific type of BC, and potential confounding factors.

View Article and Find Full Text PDF

Background: The colon cancer prognosis is influenced by multiple factors, including clinical, pathological, and non-biological factors. However, only a few studies have focused on computed tomography (CT) imaging features. Therefore, this study aims to predict the prognosis of patients with colon cancer by combining CT imaging features with clinical and pathological characteristics, and establishes a nomogram to provide critical guidance for the individualized treatment.

View Article and Find Full Text PDF

Overexpression of SLAP2 inhibits triple-negative breast cancer progression by promoting macrophage M1-type polarization.

Sci Rep

October 2024

Department of Breast Cancer Center, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, National Key Clinical Specialty, Hubei Provincial Clinical Research Center for Breast Cancer, Wuhan Clinical Research Center for Breast Cancer, No.116 Zhuo Daoquan South Road, Wuhan, 430079, Hubei, China.

Article Synopsis
  • Breast cancer is the most prevalent cancer in women, with triple-negative breast cancer (TNBC) being particularly aggressive and difficult to treat, prompting research into potential therapeutic targets like Src-like adaptor protein 2 (SLAP2).
  • The study involved creating a lentivirus to overexpress SLAP2 in the MDA-MB-231 TNBC cell line, followed by mRNA sequencing to identify gene expression changes and potential pathways affected by SLAP2.
  • Results showed that SLAP2 overexpression led to the upregulation of 179 genes related to immune responses, inhibited tumor growth in animal models, increased tumor cell apoptosis, and encouraged the polarization of macrophages towards a type that combats tumors.
View Article and Find Full Text PDF

Background: Macrophages are key regulators of the inflammatory and innate immune responses. Researchers have shown that aberrant expression of macrophages contributes to the development of abdominal aortic aneurysms (AAA). However, a comprehensive bibliometric analysis exploring the research status and knowledge mapping of this area is lacking.

View Article and Find Full Text PDF

Early prediction of intraoperative hypothermia in patients undergoing gynecological laparoscopic surgery: A retrospective cohort study.

Medicine (Baltimore)

October 2024

Department Gynecology, Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.

Article Synopsis
  • * A study was conducted using data from 1429 patients who underwent gynecological laparoscopic surgery between June 2018 and May 2023, focusing on various factors that contribute to hypothermia.
  • * The random forest machine learning model demonstrated the best predictive performance with high accuracy, significantly aiding healthcare professionals in assessing the risk of intraoperative hypothermia.
View Article and Find Full Text PDF

Purpose: First-line tislelizumab plus chemotherapy significantly improved progression-free survival (PFS) versus chemotherapy alone in advanced squamous non-small-cell lung cancer (sq-NSCLC) at the interim analysis of the phase III RATIONALE-307 trial. We present the final analysis of this trial.

Patients And Methods: Patients with treatment-naive, stage IIIB/IV, sq-NSCLC were randomized (1 : 1: 1) to 21-day cycles of i.

View Article and Find Full Text PDF

Background: The purpose of this study was to report an updated, final analysis with longer follow-up for the open-label phase III RATIONALE-304 study of first-line tislelizumab plus chemotherapy versus chemotherapy alone for advanced nonsquamous non-small-cell lung cancer (nsq-NSCLC).

Materials And Methods: Patients with histologically confirmed stage IIIB/IV nsq-NSCLC were randomized (2 : 1) to 4-6 cycles of tislelizumab plus platinum-based chemotherapy and pemetrexed every 3 weeks, followed by maintenance tislelizumab and pemetrexed, or platinum-based chemotherapy and pemetrexed alone every 3 weeks followed by maintenance pemetrexed. The primary endpoint was independent review committee (IRC)-assessed progression-free survival (PFS).

View Article and Find Full Text PDF
Article Synopsis
  • A phase 3 trial compared the effectiveness and safety of zuberitamab combined with CHOP chemotherapy (Hi-CHOP) against rituximab combined with CHOP (R-CHOP) in patients with untreated CD20-positive diffuse large B-cell lymphoma (DLBCL).
  • The trial involved 487 patients, with a primary focus on the objective response rate (ORR) after six treatment cycles, finding that Hi-CHOP achieved a similar ORR to R-CHOP while demonstrating a significantly higher complete response (CR) rate in some analyses.
  • Long-term follow-up indicated that Hi-CHOP patients experienced improved duration of response (DOR), progression-free survival (PFS), and overall survival
View Article and Find Full Text PDF

The role of post-translational modifications of cGAS in γδ T cells.

Mol Immunol

November 2024

Institute of Reproductive Health, Center for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address:

Cyclic GMP-AMP (cGAMP) synthase (cGAS) senses DNA in a sequence-independent manner, triggering cGAMP synthesis, which activates stimulator of interferon genes (STING) and the subsequent expression of type I interferons, tumour necrosis factor alpha (TNF-α) and other proinflammatory factors in two downstream pathways. However, the function of the cGASSTING pathway in γδ T cells remains unclear. The γδ T-cell population differs from the innate-like lymphocyte population, particularly with respect to tissue distribution, indicating the unique potential of γδ T cells in treating infections and cancers.

View Article and Find Full Text PDF

Objective: To explore the relationship between dietary flavonoids and bronchitis, emphysema and asthma.

Method: A total of 11743 United States adults were extracted from the National Health and Nutrition Examination Survey (NHANES) in 2007-2008, 2009-2010 and 2017-2018. Of these, 47.

View Article and Find Full Text PDF

Background: Retrospective analysis to identify the risk factors for air embolism following computed tomography (CT)-guided percutaneous transthoracic needle biopsy (TNB).

Methods: A retrospective analysis of patients who underwent CT-TNB at The First Affiliated Hospital of Zhengzhou University and Xuzhou Cancer Hospital from January 2017 to December 2021 was performed. A total of 21 factors relevant to air embolisms were collected.

View Article and Find Full Text PDF
Article Synopsis
  • * In this phase 3, double-blind trial, 445 women were randomly assigned to receive either cadonilimab with chemotherapy or a placebo with chemotherapy, with results measured over time for progression-free and overall survival.
  • * Findings showed that patients receiving cadonilimab experienced a median progression-free survival of 12.7 months compared to 8.1 months for the placebo group, along with improved overall survival,
View Article and Find Full Text PDF

Correlation of PSA and survival in metastatic hormone-sensitive prostate cancer treated with rezvilutamide plus ADT in the CHART trial.

Med

October 2024

Department of Urology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China; Cancer Institute, Shanghai Urological Cancer Institute, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China. Electronic address:

Article Synopsis
  • The CHART trial explored the relationship between prostate-specific antigen (PSA) levels and survival outcomes in patients with high-volume, metastatic, hormone-sensitive prostate cancer (mHSPC), involving 654 participants divided between two treatment groups.
  • Patients taking rezvilutamide plus androgen deprivation therapy (ADT) had significantly better PSA reductions (≥50% PSA reduction at 98.2% versus 87.5% and ≥90% reduction at 88.7% versus 63.1%) compared to those on bicalutamide plus ADT, indicating it may be more effective in delaying PSA progression.
  • Achieving undetectable PSA levels and ≥90% PSA reduction with rezvilutamide was linked to
View Article and Find Full Text PDF
Article Synopsis
  • * The rise of machine algorithms, especially in deep learning and machine learning, offers new ways to analyze clinical data and improve prognostic assessments in liver cancer patients through identifying patterns.
  • * Key challenges remain in this field, such as integrating diverse clinical data, addressing ethical concerns, and ensuring the transparency of how these algorithms make decisions, which this paper aims to address through a systematic review.
View Article and Find Full Text PDF

Targeting the LMP1-ALIX axis in EBV nasopharyngeal carcinoma inhibits immunosuppressive small extracellular vesicle secretion and boosts anti-tumor immunity.

Cancer Commun (Lond)

December 2024

Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P. R. China.

Article Synopsis
  • Immunotherapy for nasopharyngeal carcinoma (NPC) is effective but has low response rates; the role of PD-L1 on small extracellular vesicles (sEVs) in tumor immunosuppression is a key focus of research.
  • The study investigates how the Epstein-Barr virus protein LMP1 influences tumor immunity in NPC by analyzing T cell presence and sEV characteristics in both human tissues and mouse models.
  • Results show that high LMP1 levels limit CD8 T cell infiltration and promote PD-L1 secretion through interactions with ALIX, suggesting a potential pathway for therapeutic intervention to enhance immune responses in NPC.
View Article and Find Full Text PDF

Purpose: We aim to detect the effects of sivelestat on renal ischemia-reperfusion associated with AKI and also explore the underlying mechanism.

Materials And Methods: Mice, aged between 8 and 12 weeks, were randomly allocated among four distinct groups, respectively normal saline sham group(C), normal saline surgery group(I), sivelestat (50 mg/kg) sham group(S), sivelestat (50 mg/kg) surgery group(SI) (n=6, each group). In the surgical groups, the renal pedicles of mice were clamped with non-traumatic micro-aneurysm clamps, resulting in ischemia of the kidneys for 45 minutes.

View Article and Find Full Text PDF

First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial.

Med

January 2025

Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China. Electronic address:

Article Synopsis
  • Zorifertinib is an experimental cancer drug that targets mutations in the EGFR gene and has shown effectiveness in patients with lung cancer that has spread to the brain.
  • A phase 3 trial compared zorifertinib to standard treatments and found that it significantly extended the time patients lived without the disease worsening (progression-free survival).
  • Results indicate that zorifertinib may be a better first-line treatment option for non-small cell lung cancer due to its ability to improve survival and manage side effects effectively.
View Article and Find Full Text PDF

[Thoracic splenosis: report of a case].

Zhonghua Bing Li Xue Za Zhi

October 2024

Department of Pathology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, China.

View Article and Find Full Text PDF

Potent covalent irreversible inhibitor of KRAS G12C IBI351 in patients with advanced solid tumors: First-in-human phase I study.

Eur J Cancer

November 2024

Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. Electronic address:

Article Synopsis
  • IBI351 is an irreversible, covalent inhibitor specifically targeting the KRAS G12C mutation in advanced solid tumors, particularly among Chinese patients, addressing unmet clinical needs even after FDA-approved therapies exist.
  • In a clinical study involving 176 patients, various doses of IBI351 were tested, with the recommended dose set at 600 mg taken twice daily, showing no major toxic effects while still being effective.
  • The treatment demonstrated a 45.5% overall response rate in patients with non-small cell lung cancer, with promising results, including a 9.6-month median progression-free survival at the optimal dosage.
View Article and Find Full Text PDF

Background: Stomach adenocarcinoma (STAD) is a major contributor to cancer-related mortality worldwide. Alterations in amino acid metabolism, which is integral to protein synthesis, have been observed across various tumor types. However, the prognostic significance of amino acid metabolism-related genes in STAD remains underexplored.

View Article and Find Full Text PDF

Analysis of dietary inflammatory potential and mortality in cancer survivors using NHANES data.

Front Nutr

September 2024

Department of Radiotherapy Center, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Article Synopsis
  • Inflammation is a key factor in cancer progression and prognosis, making diet a potentially modifiable risk factor for cancer outcomes in the U.S., where cancer is a leading cause of death.
  • This study analyzed data from the National Health and Nutrition Examination Survey (1999-2018) to explore the link between the Dietary Inflammatory Index (DII) and mortality rates among 3,011 cancer survivors.
  • Results showed that higher DII scores were significantly associated with increased risks of overall mortality (10% per unit increase) and cancer-related mortality (13% per unit increase), suggesting that adopting an anti-inflammatory diet could enhance survival for those who have survived cancer.
View Article and Find Full Text PDF

Context: Sarcopenia has been identified as a potential predictor of poor prognosis in various types of cancer. However, the impact of pretreatment sarcopenia and the reduction of skeletal muscle mass during treatment on survival outcomes of patients with cervical cancer is still not well understood.

Objective: This meta-analysis was conducted to investigate the impact of pretreatment sarcopenia and treatment-associated muscle loss on survival outcomes in patients with cervical cancer.

View Article and Find Full Text PDF

Peripheral neurotoxicity induced by albumin-bound paclitaxel: a case report.

Front Oncol

September 2024

Department of Pharmacy, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Article Synopsis
  • A 70-year-old male with non-small cell lung cancer (NSCLC) experienced peripheral neurotoxicity after receiving albumin-bound paclitaxel, leading to limb weakness and numbness.
  • *After switching to a regimen of liposomal paclitaxel, cisplatin, and tislelizumab, his symptoms improved.
  • *The tumor showed a partial response, suggesting that the new treatment may help manage neurotoxicity while effectively treating NSCLC.
View Article and Find Full Text PDF